Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Vertex Pharmaceuticals (IT:1VRTX)

:1VRTX

1VRTX

Vertex Pharmaceuticals

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Vertex Pharmaceuticals (1VRTX) Ratios

Compare

4 Followers

Vertex Pharmaceuticals Ratios

IT:1VRTX's free cash flow for Q1 2025 was $0.87. For the 2025 fiscal year, IT:1VRTX's free cash flow was decreased by $ and operating cash flow was $0.26. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	5.22	3.99	5.22	4.81	5.02
Quick Ratio	5.03	3.78	5.03	4.62	4.84
Cash Ratio	4.32	2.92	4.32	3.63	3.84
Solvency Ratio	0.82	0.74	0.82	0.74	0.92
Operating Cash Flow Ratio	1.70	1.00	1.70	1.41	2.09
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	-10.25
Net Current Asset Value	$ 8.44B	$ 8.99B	$ 8.44B	$ 5.68B	$ 4.76B
Leverage Ratios
Debt-to-Assets Ratio	0.03	0.04	0.03	0.04	0.05
Debt-to-Equity Ratio	0.04	0.05	0.04	0.06	0.07
Debt-to-Capital Ratio	0.04	0.04	0.04	0.05	0.06
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.30	1.29	1.30	1.33	1.35
Debt Service Coverage Ratio	64.33	87.19	64.33	41.13	-11.11
Interest Coverage Ratio	78.60	86.89	78.60	45.24	49.12
Debt to Market Cap	0.00	0.00	0.00	0.00	>-0.01
Interest Debt Per Share	2.40	3.31	2.40	2.40	2.46
Net Debt to EBITDA	-2.24	-2.08	-2.24	-2.14	-1.65
Profitability Margins
Gross Profit Margin	87.90%	87.21%	87.90%	88.06%	88.14%
EBIT Margin	48.01%	44.83%	48.01%	36.86%	51.16%
EBITDA Margin	49.67%	46.66%	49.67%	38.52%	52.93%
Operating Profit Margin	48.23%	38.83%	48.23%	36.73%	46.03%
Pretax Profit Margin	47.39%	44.38%	47.39%	36.05%	50.22%
Net Profit Margin	37.20%	36.68%	37.20%	30.92%	43.70%
Continuous Operations Profit Margin	37.20%	36.68%	37.20%	30.92%	43.70%
Net Income Per EBT	78.49%	82.64%	78.49%	85.78%	87.00%
EBT Per EBIT	98.26%	114.30%	98.26%	98.14%	109.12%
Return on Assets (ROA)	18.30%	15.92%	18.30%	17.44%	23.07%
Return on Equity (ROE)	23.88%	20.59%	23.88%	23.19%	31.22%
Return on Capital Employed (ROCE)	27.40%	19.98%	27.40%	24.07%	28.03%
Return on Invested Capital (ROIC)	21.38%	16.44%	21.38%	20.50%	25.06%
Return on Tangible Assets	20.18%	17.40%	20.18%	19.47%	26.20%
Earnings Yield	4.49%	3.45%	4.49%	4.14%	4.42%
Efficiency Ratios
Receivables Turnover	6.19	6.31	6.19	6.66	7.01
Payables Turnover	3.55	3.46	3.55	4.64	4.75
Inventory Turnover	2.35	1.71	2.35	2.56	2.62
Fixed Asset Turnover	8.06	6.79	8.06	6.92	6.47
Asset Turnover	0.49	0.43	0.49	0.56	0.53
Working Capital Turnover Ratio	1.03	0.94	1.03	1.13	1.28
Cash Conversion Cycle	111.89	165.94	111.89	118.60	114.36
Days of Sales Outstanding	58.94	57.82	58.94	54.78	52.07
Days of Inventory Outstanding	155.62	213.64	155.62	142.54	139.19
Days of Payables Outstanding	102.68	105.52	102.68	78.72	76.91
Operating Cycle	214.57	271.46	214.57	197.32	191.26
Cash Flow Ratios
Operating Cash Flow Per Share	16.13	13.73	16.13	10.26	12.52
Free Cash Flow Per Share	15.33	12.72	15.33	9.35	11.52
CapEx Per Share	0.80	1.00	0.80	0.91	1.00
Free Cash Flow to Operating Cash Flow	0.95	0.93	0.95	0.91	0.92
Dividend Paid and CapEx Coverage Ratio	20.18	13.69	20.18	11.25	12.52
Capital Expenditure Coverage Ratio	20.18	13.69	20.18	11.25	12.52
Operating Cash Flow Coverage Ratio	7.36	4.38	7.36	4.75	5.60
Operating Cash Flow to Sales Ratio	0.46	0.36	0.46	0.35	0.52
Free Cash Flow Yield	5.31%	3.13%	5.31%	4.26%	4.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	22.26	28.97	22.26	24.16	22.65
Price-to-Sales (P/S) Ratio	8.28	10.62	8.28	7.47	9.90
Price-to-Book (P/B) Ratio	5.32	5.96	5.32	5.60	7.07
Price-to-Free Cash Flow (P/FCF) Ratio	18.84	31.98	18.84	23.50	20.51
Price-to-Operating Cash Flow Ratio	17.91	29.64	17.91	21.41	18.88
Price-to-Earnings Growth (PEG) Ratio	0.52	3.48	0.52	-1.87	0.18
Price-to-Fair Value	5.32	5.96	5.32	5.60	7.07
Enterprise Value Multiple	14.43	20.69	14.43	17.26	17.05
Enterprise Value	64.01B	95.29B	64.01B	50.35B	56.00B
EV to EBITDA	14.43	20.69	14.43	17.26	17.05
EV to Sales	7.17	9.66	7.17	6.65	9.02
EV to Free Cash Flow	16.31	29.06	16.31	20.91	18.71
EV to Operating Cash Flow	15.50	26.94	15.50	19.05	17.21
Tangible Book Value Per Share	47.72	60.74	47.72	32.20	26.50
Shareholders’ Equity Per Share	54.33	68.22	54.33	39.19	33.43
Tax and Other Ratios
Effective Tax Rate	0.22	0.17	0.22	0.14	0.13
Revenue Per Share	34.87	38.30	34.87	29.39	23.88
Net Income Per Share	12.97	14.05	12.97	9.09	10.44
Tax Burden	0.78	0.83	0.78	0.86	0.87
Interest Burden	0.99	0.99	0.99	0.98	0.98
Research & Development to Revenue	0.28	0.32	0.28	0.40	0.29
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.06	0.06	0.06	0.06	0.07
Income Quality	1.24	0.98	1.24	1.13	1.20

Currency in USD

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing